Health Benefits of Expressive Writing Among Chinese Breast Cancer Survivors

Sponsor
University of Houston (Other)
Overall Status
Completed
CT.gov ID
NCT02946619
Collaborator
American Cancer Society, Inc. (Other), Herald Cancer Association (Other)
136
2
3
45
68
1.5

Study Details

Study Description

Brief Summary

This study is a randomized controlled trial (RCT) with the aim of determining the cultural sensitivity, feasibility, and effectiveness of an expressive writing intervention for Chinese breast cancer survivors.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Self-Regulation Condition
  • Behavioral: Enhanced self-Regulation Condition
N/A

Detailed Description

The study examines the potential health benefits (i.e., physical health, psychological health, and quality of life) of this expressive writing intervention for Chinese-speaking breast cancer survivors. The study also explores the mechanism through which expressive writing confers health benefits and investigates who will benefit most from the expressive writing intervention. Chinese-speaking breast cancer survivors who have completed primary treatment will be randomly assigned to a control writing condition, a self-regulation condition, or a enhanced self-regulation writing condition. Health outcomes are assessed at baseline, and 1, 3, and 6 months follow-ups. Mixed qualitative-quantitative mixed methods are used to explore the effect of the intervention on health outcomes and explore the mechanisms that explain the benefits of this intervention.

Study Design

Study Type:
Interventional
Actual Enrollment :
136 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Triple (Participant, Investigator, Outcomes Assessor)
Primary Purpose:
Supportive Care
Official Title:
Reducing Psychological Burdens Among Chinese Breast Cancer Survivors
Study Start Date :
Jun 1, 2012
Actual Primary Completion Date :
Mar 1, 2016
Actual Study Completion Date :
Mar 1, 2016

Arms and Interventions

Arm Intervention/Treatment
No Intervention: Control Condition

Participants in the control group were asked to write for three weeks about facts regarding their cancer and its treatment for three sessions.

Experimental: Self-regulation condition

For the self-regulation condition, each weekly writing assignment covers a different task. During session one, participants will be asked to write about their deepest feelings and thoughts regarding their experience with breast cancer as well as its impact on their lives; in session two, participants will be asked to write about their coping strategies to deal with stressors associated with the cancer diagnosis and treatment, as well as future plans for coping with cancer-related stressors; and in session three, participants will be asked to write about positive thoughts and feelings regarding their experience with breast cancer.

Behavioral: Self-Regulation Condition

Experimental: Enhanced self-regulation condition

For the enhanced self-regulation condition, each weekly writing assignment covers a different task. During session one, participants will be asked to write about their coping strategies to deal with stressors associated with the cancer diagnosis and treatment, as well as future plans for coping with cancer-related stressors; during session two, participants will be asked to write about their deepest feelings and thoughts regarding their experience with breast cancer as well as its impact on their lives; and in session three, participants will be asked to write about positive thoughts and feelings regarding their experience with breast cancer.

Behavioral: Enhanced self-Regulation Condition

Outcome Measures

Primary Outcome Measures

  1. Change in quality of life score as assessed by the Functional Assessment of Cancer Therapy Scale (FACT) [Baseline, 1 month, 3 months, and 6 months follow-ups after the intervention.]

    The Functional Assessment of Cancer Therapy Scale (FACT) is a 27-item measure of health-related quality of life (Cella & Tulsky,1993), which assesses perceived life quality in four different facets, including physical well-being (7 items,score range 0 - 28), social well-being (7 items, score range 0 - 28), emotional well-being (6 items, score range 0-24), and functional well-being (7 items, score range 0-28). A higher subscale score indicates better functioning in the corresponding domain. Total score is computed by summing up the scores of the four subscales. Total score ranges from 0 to 108. A higher score indicates better quality of life.

Secondary Outcome Measures

  1. Change in posttraumatic stress disorder (PTSD), as assessed by the PTSD Symptom Scale - Self Report version (PSS-SR) [Baseline, 1 month, 3 months, and 6 months follow-ups after the intervention.]

    The scale contains 17 items reflecting the Diagnostic and Statistical Manual of Mental Disorders-Fourth Edition -Text Revision (DSM-IV-TR) symptoms of post-traumatic stress disorder (Foa, Riggs, Dancu, & Rothbaum, 1993). Score can be reported in terms of total score or the score of the three subscales (Re-experiencing, Avoidance and Hyperarousal). The score ranges for the three sub-scales are: Re-experiencing symptoms (5 items, 0-15), Avoidance symptoms (7 items, 0 -21) and Hyperarousal symptoms (5 items, 0-15). Each subscale score is computed by summing up the scores of the corresponding items. For each subscale, a higher score indicates more severe symptoms. The total score is computed by summing up the scores of the three subscales. The total score ranges from 0 to 51. A higher score indicated more severe PTSD symptoms.

  2. Change in fatigue as assessed by Functional Assessment of Chronic Illness Therapy-Fatigue Scale (FACIT-F) [Baseline, 1 month, 3 months, and 6 months follow-ups after the intervention.]

    The scale contains 13 items. Total score is computed by summing up the scores of all the 13 items. The total score ranges from 0 to 52. A higher score indicates more severe fatigue symptoms.

  3. Change in depressive symptoms as assessed by Center for Epidemiologic Studies Depression Scale (CES-D). [Baseline, 1 month, 3 months, and 6 months follow-ups after the intervention.]

    The scale contains 10 items. Total score is computed by summing up the scores of all the 10 items. Total score ranges from 0 to 30. A higher scores indicates more severe depression symptoms.

  4. Change in anxiety as assessed by Brief Symptom Inventory (BSI)-anxiety dimension [Baseline, 1 month, 3 months, and 6 months follow-ups after the intervention.]

    The scale contains 6 items. Total score is computed by summing up the scores of all the 6 items. Total score ranges from 0 - 24. A higher score indicates more severe anxiety symptoms.

  5. Change in physical symptoms as assessed by the Physical Symptoms Checklist [Baseline, 1 month, 3 months, and 6 months follow-ups after the intervention.]

    The scale contains 10 items. Total score is computed by summing up the scores of all the 10 items. Total score ranges from 0 - 300. A higher score indicates more severe physical symptoms.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  1. having a breast cancer diagnosis; 2) completing breast cancer surgery within five years; and 3) being comfortable writing and speaking Chinese (i.e. Mandarin or Cantonese)

Contacts and Locations

Locations

Site City State Country Postal Code
1 Herald Cancer Association Los Angeles California United States 91776
2 University of Houston Houston Texas United States 77204

Sponsors and Collaborators

  • University of Houston
  • American Cancer Society, Inc.
  • Herald Cancer Association

Investigators

  • Principal Investigator: Qian Lu, Ph.D., MD, University of Houston

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Qian Lu, Associate Professor, University of Houston
ClinicalTrials.gov Identifier:
NCT02946619
Other Study ID Numbers:
  • MRSGT-10-011-01-CPPB
First Posted:
Oct 27, 2016
Last Update Posted:
Sep 4, 2019
Last Verified:
Sep 1, 2019
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Keywords provided by Qian Lu, Associate Professor, University of Houston
Additional relevant MeSH terms:

Study Results

No Results Posted as of Sep 4, 2019